Literature DB >> 21518865

Polycystin-1 regulates STAT activity by a dual mechanism.

Jeffrey J Talbot1, Jonathan M Shillingford, Shivakumar Vasanth, Nicholas Doerr, Sambuddho Mukherjee, Mike T Kinter, Terry Watnick, Thomas Weimbs.   

Abstract

Mutations in polycystin-1 (PC1) lead to autosomal-dominant polycystic kidney disease (ADPKD), a leading cause of renal failure for which no treatment is available. PC1 is an integral membrane protein, which has been implicated in the regulation of multiple signaling pathways including the JAK/STAT pathway. Here we show that membrane-anchored PC1 activates STAT3 in a JAK2-dependent manner, leading to tyrosine phosphorylation and transcriptional activity. The C-terminal cytoplasmic tail of PC1 can undergo proteolytic cleavage and nuclear translocation. Tail-cleavage abolishes the ability of PC1 to directly activate STAT3 but the cleaved PC1 tail now coactivates STAT3 in a mechanism requiring STAT phosphorylation by cytokines or growth factors. This leads to an exaggerated cytokine response. Hence, PC1 can regulate STAT activity by a dual mechanism. In ADPKD kidneys PC1 tail fragments are overexpressed, including a unique ∼15-kDa fragment (P15). STAT3 is strongly activated in cyst-lining epithelial cells in human ADPKD, and orthologous and nonorthologous polycystic mouse models. STAT3 is also activated in developing, postnatal kidneys but inactivated in adult kidneys. These results indicate that STAT3 signaling is regulated by PC1 and is a driving factor for renal epithelial proliferation during normal renal development and during cyst growth.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21518865      PMCID: PMC3093515          DOI: 10.1073/pnas.1103816108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

Review 1.  IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled.

Authors:  E P Reddy; A Korapati; P Chaturvedi; S Rane
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

2.  Photochemical preparation of a pyridone containing tetracycle: a Jak protein kinase inhibitor.

Authors:  James E Thompson; Rose M Cubbon; Richard T Cummings; Linda S Wicker; Robert Frankshun; Barry R Cunningham; Patricia M Cameron; Peter T Meinke; Nigel Liverton; Youmin Weng; Julie A DeMartino
Journal:  Bioorg Med Chem Lett       Date:  2002-04-22       Impact factor: 2.823

Review 3.  The STATs of cancer--new molecular targets come of age.

Authors:  Hua Yu; Richard Jove
Journal:  Nat Rev Cancer       Date:  2004-02       Impact factor: 60.716

4.  Cleavage of polycystin-1 requires the receptor for egg jelly domain and is disrupted by human autosomal-dominant polycystic kidney disease 1-associated mutations.

Authors:  Feng Qian; Alessandra Boletta; Anil K Bhunia; Hangxue Xu; Lijuan Liu; Ali K Ahrabi; Terry J Watnick; Fang Zhou; Gregory G Germino
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-13       Impact factor: 11.205

5.  Positional cloning of jcpk/bpk locus of the mouse.

Authors:  Cathy Cogswell; Sarah J Price; Xiaoying Hou; Lisa M Guay-Woodford; Lorraine Flaherty; Elizabeth C Bryda
Journal:  Mamm Genome       Date:  2003-04       Impact factor: 2.957

Review 6.  Molecular advances in autosomal dominant polycystic kidney disease.

Authors:  Anna Rachel Gallagher; Gregory G Germino; Stefan Somlo
Journal:  Adv Chronic Kidney Dis       Date:  2010-03       Impact factor: 3.620

7.  PKD1 induces p21(waf1) and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2.

Authors:  Anil Kumar Bhunia; Klaus Piontek; Alessandra Boletta; Lijuan Liu; Feng Qian; Pei Ning Xu; F Joseph Germino; Gregory G Germino
Journal:  Cell       Date:  2002-04-19       Impact factor: 41.582

Review 8.  Autosomal dominant polycystic kidney disease: molecular genetics and pathophysiology.

Authors:  Michael Sutters; Gregory G Germino
Journal:  J Lab Clin Med       Date:  2003-02

9.  Renal and biliary abnormalities in a new murine model of autosomal recessive polycystic kidney disease.

Authors:  J Nauta; Y Ozawa; W E Sweeney; J C Rutledge; E D Avner
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

10.  Delayed cystogenesis and increased ciliogenesis associated with the re-expression of polaris in Tg737 mutant mice.

Authors:  Nicole E Brown; Noel S Murcia
Journal:  Kidney Int       Date:  2003-04       Impact factor: 10.612

View more
  64 in total

1.  Scattered Deletion of PKD1 in Kidneys Causes a Cystic Snowball Effect and Recapitulates Polycystic Kidney Disease.

Authors:  Wouter N Leonhard; Malu Zandbergen; Kimberley Veraar; Susan van den Berg; Louise van der Weerd; Martijn Breuning; Emile de Heer; Dorien J M Peters
Journal:  J Am Soc Nephrol       Date:  2014-10-31       Impact factor: 10.121

Review 2.  How insights from cardiovascular developmental biology have impacted the care of infants and children with congenital heart disease.

Authors:  Alvin J Chin; Jean-Pierre Saint-Jeannet; Cecilia W Lo
Journal:  Mech Dev       Date:  2012-05-26       Impact factor: 1.882

Review 3.  Vasopressin and disruption of calcium signalling in polycystic kidney disease.

Authors:  Fouad T Chebib; Caroline R Sussman; Xiaofang Wang; Peter C Harris; Vicente E Torres
Journal:  Nat Rev Nephrol       Date:  2015-04-14       Impact factor: 28.314

Review 4.  STAT signaling in polycystic kidney disease.

Authors:  Sebastian Strubl; Jacob A Torres; Alison K Spindt; Hannah Pellegrini; Max C Liebau; Thomas Weimbs
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

Review 5.  Src family kinases in chronic kidney disease.

Authors:  Jun Wang; Shougang Zhuang
Journal:  Am J Physiol Renal Physiol       Date:  2017-06-14

6.  Polycystin-1 regulates bone development through an interaction with the transcriptional coactivator TAZ.

Authors:  David Merrick; Kavita Mistry; Jingshing Wu; Nikolay Gresko; Julie E Baggs; John B Hogenesch; Zhaoxia Sun; Michael J Caplan
Journal:  Hum Mol Genet       Date:  2019-01-01       Impact factor: 6.150

Review 7.  Molecular pathways and therapies in autosomal-dominant polycystic kidney disease.

Authors:  Takamitsu Saigusa; P Darwin Bell
Journal:  Physiology (Bethesda)       Date:  2015-05

Review 8.  A cut above (and below): Protein cleavage in the regulation of polycystin trafficking and signaling.

Authors:  Valeria Padovano; Kavita Mistry; David Merrick; Nikolay Gresko; Michael J Caplan
Journal:  Cell Signal       Date:  2020-04-10       Impact factor: 4.315

9.  Mechanosensor polycystin-1 potentiates differentiation of human osteoblastic cells by upregulating Runx2 expression via induction of JAK2/STAT3 signaling axis.

Authors:  Georgia Dalagiorgou; Christina Piperi; Christos Adamopoulos; Urania Georgopoulou; Antonios N Gargalionis; Anastasia Spyropoulou; Ilianna Zoi; Marjan Nokhbehsaim; Anna Damanaki; James Deschner; Efthimia K Basdra; Athanasios G Papavassiliou
Journal:  Cell Mol Life Sci       Date:  2016-10-03       Impact factor: 9.261

10.  Bardet-Biedl syndrome proteins 1 and 3 regulate the ciliary trafficking of polycystic kidney disease 1 protein.

Authors:  Xuefeng Su; Kaitlin Driscoll; Gang Yao; Anas Raed; Maoqing Wu; Philip L Beales; Jing Zhou
Journal:  Hum Mol Genet       Date:  2014-06-16       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.